Here are relevant reports on : stented-heart-valve-market
-
Cardiac Perfusion Market by Product (Oxygenation Systems, Reservoirs, Heart-Lung Machines, Arterial Filters, Heat Transfer Systems, Blood Monitoring Systems, Auto transfusion Systems) - Forecast to 2020
Cardiac perfusion systems are used to temporarily replace the functions of the heart during cardiac surgeries. The cardiac perfusion system market is broadly segmented into oxygenation systems, reservoirs, heart-lung machines, myocardial protection systems, arterial filters, blood monitoring systems, autotransfusion systems, hemoconcentrators, heat transfer systems, tubings and cannulae, and others. The pivotal factor driving the growth of this market is increasing number of cardiac surgeries. Increasing prevalence of cardiac and lung diseases in developed as well as developing further propels the growth of this market. However, insufficient number of well-trained surgeons in developing nations, unstable reimbursement policies, and competition from local players with low cost products are inhibits the growth of this market. North America is the largest market for cardiac perfusion system market, with the U.S. contributing a major share, followed by Europe, Asia-Pacific, and the Rest of the World. North America and Europe will continue to dominate the market during the forecast period owing to the growing number of cardiac and lung surgeries and technological advancement in cardiac perfusion system. However, a majority of the growth in the cardiac perfusion system market is expected to be from emerging markets in the Asia-Pacific, owing to the growing number of cardiovascular patients, increasing awareness towards healthcare, and technological advancement in cardiovascular surgery in these regions.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) & Region - Global Forecast to 2029
The global cardiac monitoring & cardiac rhythm management devices market, valued at US$20.7 billion in 2023, stood at US$21.3 billion in 2024 and is projected to advance at a resilient CAGR of 4.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.4 billion by the end of the period. Market growth in the Asia Pacific can be attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking, and rising morbidity and mortality from CVD.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Primary Cells Market by Type (Hematopoietic, Dermatocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, Musculoskeletal), Origin (Human Primary Cells, Animal Primary Cells), End User (Pharma Biotech, CROs, Academia), Region - Global Forecast to 2028
The global primary cells market, valued at US$1.5 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 10.5% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The growth of this market can be attributed to factors such as the is the growing advantages of primary human cells over cell lines, rising growth in pharmaceutical & biotechnology industries, increasing demand for monoclonal antibodies, Government investments for cell-based research, and increasing cancer research.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027
The global vascular patches market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period. The vascular patches market is dominated by players such as Baxter International, Inc. (US), LeMaitre Vascular, Inc. (US), and W. L. Gore & Associates, Inc. (US).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021
The global perfusion systems market is expected to reach USD 1,198.8 Million by 2021 from USD 989.4 Million in 2016, at a CAGR of 3.9%. The growth of the market can be attributed to the increasing prevalence of cardiovascular & respiratory diseases, initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Heart Health Ingredients Market By Types (Phtosterols, Omega-3 PUFA, Beta-Glucan, U.S. Soy Ingredients, others) By Geography (NA, APAC, Europe & ROW)
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Heart Health Ingredients Market By Types (Phtosterols, Omega-3 PUFA, Beta-Glucan, U.S. Soy Ingredients, others) By Geography (NA, APAC, Europe & ROW)
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
US Interventional Cardiology Devices Market by Type (Stents, Balloons, Structural Heart, Angio Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration, Guidewire, Introducer Sheaths), End User (Hospitals, Cardiac Centers) - Forecast to 2031
The US interventional cardiology devices market, valued at USD 12.09 billion in 2025, stood at USD 12.82 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 17.75 billion by the end of the period. The market is driven by the increasing number of cases of heart and blood vessel diseases, especially coronary artery disease and heart valve disorders, and the aging population.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Organ Preservation Market by Solution Type (UW, Custodial HTK, Perfadex), Technique (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidneys, Liver, Heart), End User (Transplant Centers, Hospitals, Specialty Clinics) - Global Forecast to 2030
The global organ preservation market, valued at US$0.1 billion in 2024, stood at US$0.2 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The organ preservation market is experiencing robust growth fueled by rising incidence of chronic diseases, organ failure, and advancements in transplantation procedures.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Electroceuticals Market / Bioelectric Medicine Market by Product (Cardiac Pacemakers, ICD, Cochlear Implant, Neuromodulation (Deep Brain Stimulation)), Type (Implantable, Non-Invasive), Application (Arrhythmia, Heart Failure, Epilepsy) & Region - Global Forecast to 2029
The global electroceuticals market, valued at US$21.9 billion in 2023, stood at US$23.9 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Growth of the overall market is largely driven by the increasing incidence of cardiovascular, hearing loss and neurological disorders, increasing research in these field of disorders, and rising awareness regarding electroceuticals devices.
- Published: March 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
